Articles by Jürgen K. Rockstroh

CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C

Kokordelis, Pavlos; Krämer, Benjamin; Boesecke, Christoph; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(4):338-346, December 1st, 2015.

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF...

Clumeck, Nathan; Molina, Jean-Michel; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):e121-e124, March 1st, 2014.

Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From...

Rockstroh, Jürgen K.; DeJesus, Edwin; Lennox, Jeffrey L.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1):77-85, May 1st, 2013.

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and...

Rockstroh, Jürgen K.; DeJesus, Edwin; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(5):483-486, April 15th, 2013.